查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1705315

2025年哺乳动物细胞发酵技术全球市场报告

Mammalian Cell Fermentation Technology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年哺乳动物细胞发酵技术的市场规模将快速成长。到 2029 年，这一数字将成长至 895.4 亿美元，复合年增长率为 11.7%。预测期内的成长可归因于慢性病盛行率的增加、跨国公司的投资增加、慢性病发生率的增加、先进生物加工技术的采用增加、新型重组蛋白研发的投资增加以及癌症治疗的需求增加。预测期内的关键趋势包括细胞培养技术进步、生物反应器设计技术进步、下一代生物加工技术的开发、多体学方法的整合以及技术主导的自动化。

预计未来几年对生技药品的需求不断增长将推动哺乳动物细胞发酵技术市场的成长。生技药品是从生物体或其成分中提取的药物，常用于治疗癌症、自体免疫疾病和感染疾病疾病。生技药品需求的不断增长得益于生物技术的进步、其在治疗流行慢性疾病方面的有效性、监管部门的核准以及研发投入的增加。哺乳动物细胞发酵技术对于生产复杂的生技药品和满足日益增长的个人化、标靶治疗的需求至关重要。它的可扩展性、多功能性和生产高品质蛋白质的能力推动了生物製药行业的创新。例如，美国国家医学图书馆2024年2月报告称，食品药物管理局（FDA）在2023年核准了55种新药，其中29种为新化学实体（NCE），25种为新生物製药（NBE），比2022年的37种增加了50%。因此，对生技药品日益增长的需求正在推动哺乳动物细胞发酵技术市场的扩张。

哺乳动物细胞发酵技术市场的主要企业正专注于开发哺乳动物细胞培养等创新解决方案，以加强其市场地位。哺乳动物细胞培养是生物製造、研究和再生医学等多个领域的重要工具，因为它有助于生产治疗性蛋白质、疫苗以及功能性细胞和组织类似物。例如，2024年6月，德国生物技术公司Syntegon在2024年Achema展会上推出了全新的模组化生物製程平台（MBP），该尖端平台旨在解决生物製药製造中的关键挑战。 MBP 是一种灵活、完全整合、自动化的解决方案，能够支援广泛的应用，包括微生物和哺乳动物细胞培养、蛋白质、胜肽、寡核苷酸、质体DNA 和重组疫苗。 MBP 的模组化设计遵循严格的「德国製造」标准，能够缩短前置作业时间和降低成本，同时保持高功能性和高品质。此外，该平台的预製无尘室设计将所有外围技术置于无尘室外，提高了效率并简化了维护，使其成为哺乳动物细胞发酵技术市场的先进解决方案。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球哺乳动物细胞发酵技术PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球哺乳动物细胞发酵技术市场：成长率分析
  • 全球哺乳动物细胞发酵技术市场表现：规模与成长，2019-2024
  • 全球哺乳动物细胞发酵技术市场预测：规模与成长，2024-2029 年，2034 年
  • 全球哺乳动物细胞发酵技术总目标市场（TAM）

第六章市场区隔

  • 全球哺乳动物细胞发酵技术市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 中国仓鼠卵巢细胞发酵
  • 人类胎肾细胞发酵
  • 幼仓鼠肾细胞发酵
  • 鼠骨髓瘤细胞发酵
  • 其他类型
  • 全球哺乳动物细胞发酵技术市场：应用、性能与预测，2019-2024 年、2024-2029 年、2034 年
  • 单株抗体
  • 重组蛋白
  • 疫苗
  • 荷尔蒙
  • 酵素
  • 其他用途
  • 全球哺乳动物细胞发酵技术市场：按最终用途、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 生物製药公司
  • 合约研究组织与合约开发与製造组织
  • 学术研究所

第七章 区域和国家分析

  • 全球哺乳动物细胞发酵技术市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球哺乳动物细胞发酵技术市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 哺乳动物细胞发酵技术市场：竞争格局
  • 哺乳动物细胞发酵技术市场：公司简介
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • Roche Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • AGC Group
  • Lonza Group Ltd.
  • Boehringer Ingelheim GmbH
  • Catalent Inc.
  • Sartorius AG
  • Samsung Biologics Co. Ltd.
  • WuXi Biologics
  • Biocon Limited
  • Eppendorf AG
  • KBI Biopharma Inc.
  • Fujifilm Diosynth Biotechnologies
  • Avid Bioservices Inc.
  • BiOZEEN
  • Nordmark Pharma GmbH
  • Scorpius BioManufacturing Inc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年哺乳动物细胞发酵技术市场：提供新机会的国家
  • 2029年哺乳动物细胞发酵技术市场：细分领域带来新机会
  • 2029年哺乳动物细胞发酵技术市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r30624

Mammalian cell fermentation technology refers to the process of cultivating mammalian cells under controlled conditions to produce biopharmaceuticals, vaccines, or other biological products. This technology involves optimizing cell growth and protein expression in bioreactors or fermenters, ensuring the production of high-quality and consistent yields of desired therapeutic proteins or substances.

The main types of mammalian cell fermentation technology include Chinese hamster ovary (CHO) cell fermentation, human embryonic kidney (HEK) cell fermentation, baby hamster kidney (BHK) cell fermentation, murine myeloma cell fermentation, and other types. Chinese hamster ovary (CHO) cell fermentation is a biotechnological process used in the production of therapeutic proteins, such as monoclonal antibodies and recombinant proteins. The various applications of mammalian cell fermentation technology include monoclonal antibodies, recombinant proteins, vaccines, hormones, enzymes, and other products. The end-users of this technology include biopharmaceutical companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and academic and research institutes.

The mammalian cell fermentation technology market research report is one of a series of new reports from The Business Research Company that provides mammalian cell fermentation technology market statistics, including mammalian cell fermentation technology industry global market size, regional shares, competitors with a mammalian cell fermentation technology market share, detailed mammalian cell fermentation technology market segments, market trends, and opportunities, and any further data you may need to thrive in the mammalian cell fermentation technology industry. This mammalian cell fermentation technology research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mammalian cell fermentation technology market size has grown rapidly in recent years. It will grow from $51.29 billion in 2024 to $57.48 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increased demand for biologics and biosimilars, increased focus on personalized medicine, increased output of biopharmaceuticals, and increased demand for scalable and effective cell culture methods.

The mammalian cell fermentation technology market size is expected to see rapid growth in the next few years. It will grow to $89.54 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to the increasing prevalence of chronic diseases, rising investments by multinational corporations, rising frequency of chronic diseases, increasing adoption of advanced bioprocessing techniques, increasing investment in research and development of novel recombinant proteins and growing demand for cancer therapies. Major trends in the forecast period include technological advancements in cell culture, technological advancements in bioreactor design, developing next-generation bioprocessing technologies, integration of multi-omics approaches, and technology-driven automation.

The increasing demand for biologics is anticipated to drive the growth of the mammalian cell fermentation technology market in the future. Biologics, which are medical products derived from living organisms or their components, are often used to treat diseases such as cancer, autoimmune disorders, and infectious diseases. The growing demand for biologics is driven by advancements in biotechnology, their effectiveness in treating prevalent chronic diseases, regulatory approvals, and increased investment in research and development. Mammalian cell fermentation technology is crucial for producing complex biologics, meeting the rising demand for personalized and targeted therapeutics. Its scalability, versatility, and ability to produce high-quality proteins foster innovation in the biopharmaceutical industry. For example, the National Library of Medicine reported in February 2024 that the Food and Drug Administration (FDA) approved 55 new drugs in 2023, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the growing demand for biologics is driving the expansion of the mammalian cell fermentation technology market.

Major companies in the mammalian cell fermentation technology market are focusing on developing innovative solutions, such as mammalian cell culture, to strengthen their market position. Mammalian cell culture is an essential tool in various fields, including biomanufacturing, research, and regenerative medicine, as it facilitates the production of therapeutic proteins, vaccines, and functional cells or tissue analogs. For example, in June 2024, Syntegon, a Germany-based biotechnology company, introduced its new Modular Bioprocessing Platform (MBP) at Achema 2024. This cutting-edge platform is designed to address key challenges in biopharmaceutical production. The MBP is a highly flexible, fully integrated, and automated solution capable of supporting a range of applications, including microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The modular design of the MBP allows for reduced lead times and costs while maintaining high functionality and quality, adhering to the rigorous "made in Germany" standard. Additionally, the platform's prefabricated cleanroom design places all peripheral technology outside the cleanroom, enhancing efficiency and simplifying maintenance, making it an advanced solution in the mammalian cell fermentation technology market.

In February 2024, Chrysea Limited, an Ireland-based biotechnology company, acquired Rodon Biologics from the Iberfar Group for an undisclosed amount. With this acquisition, Chrysea aims to strengthen its synthetic biology and biopharmaceutical development capabilities by integrating Rodon Biologics' expertise in protein engineering, cell-line development, precision fermentation, downstream processing, formulation, analytics, and production. Rodon Biologics, a Portugal-based manufacturer of biological products, operates in mammalian cell fermentation technology.

Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc

North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mammalian cell fermentation technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mammalian cell fermentation technology market consists revenues earned by entities by providing services such as cell line development, process development, cell culture and fermentation, analytical and quality control services, and formulation and fill-finish services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mammalian cell fermentation technology market also includes of sales of biosimilars, cell and gene therapy products, diagnostic enzymes and proteins, and therapeutic proteins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mammalian Cell Fermentation Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mammalian cell fermentation technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mammalian cell fermentation technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mammalian cell fermentation technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Chinese Hamster Ovary Cell Fermentation; Human Embryonic Kidney Cell Fermentation; Baby Hamster Kidney Cell Fermentation; Murine Myeloma Cell Fermentation; Other Types
  • 2) By Application: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Hormones; Enzymes; Other Applications
  • 3) By End-Use: Biopharmaceutical Companies; Contract Research Organizations And Contract Development and Manufacturing Organizations; Academic And Research Institutes
  • Companies Mentioned: AbbVie Inc.; Thermo Fisher Scientific Inc; AstraZeneca PLC; Roche Holdings Inc.; Merck KGaA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mammalian Cell Fermentation Technology Market Characteristics

3. Mammalian Cell Fermentation Technology Market Trends And Strategies

4. Mammalian Cell Fermentation Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Mammalian Cell Fermentation Technology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Mammalian Cell Fermentation Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Mammalian Cell Fermentation Technology Market Growth Rate Analysis
  • 5.4. Global Mammalian Cell Fermentation Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Mammalian Cell Fermentation Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Mammalian Cell Fermentation Technology Total Addressable Market (TAM)

6. Mammalian Cell Fermentation Technology Market Segmentation

  • 6.1. Global Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chinese Hamster Ovary Cell Fermentation
  • Human Embryonic Kidney Cell Fermentation
  • Baby Hamster Kidney Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Other Types
  • 6.2. Global Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Hormones
  • Enzymes
  • Other Applications
  • 6.3. Global Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Companies
  • Contract Research Organizations And Contract Development and Manufacturing Organizations
  • Academic And Research Institutes

7. Mammalian Cell Fermentation Technology Market Regional And Country Analysis

  • 7.1. Global Mammalian Cell Fermentation Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Mammalian Cell Fermentation Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mammalian Cell Fermentation Technology Market

  • 8.1. Asia-Pacific Mammalian Cell Fermentation Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mammalian Cell Fermentation Technology Market

  • 9.1. China Mammalian Cell Fermentation Technology Market Overview
  • 9.2. China Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mammalian Cell Fermentation Technology Market

  • 10.1. India Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mammalian Cell Fermentation Technology Market

  • 11.1. Japan Mammalian Cell Fermentation Technology Market Overview
  • 11.2. Japan Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mammalian Cell Fermentation Technology Market

  • 12.1. Australia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mammalian Cell Fermentation Technology Market

  • 13.1. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mammalian Cell Fermentation Technology Market

  • 14.1. South Korea Mammalian Cell Fermentation Technology Market Overview
  • 14.2. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mammalian Cell Fermentation Technology Market

  • 15.1. Western Europe Mammalian Cell Fermentation Technology Market Overview
  • 15.2. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mammalian Cell Fermentation Technology Market

  • 16.1. UK Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mammalian Cell Fermentation Technology Market

  • 17.1. Germany Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mammalian Cell Fermentation Technology Market

  • 18.1. France Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mammalian Cell Fermentation Technology Market

  • 19.1. Italy Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mammalian Cell Fermentation Technology Market

  • 20.1. Spain Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mammalian Cell Fermentation Technology Market

  • 21.1. Eastern Europe Mammalian Cell Fermentation Technology Market Overview
  • 21.2. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mammalian Cell Fermentation Technology Market

  • 22.1. Russia Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mammalian Cell Fermentation Technology Market

  • 23.1. North America Mammalian Cell Fermentation Technology Market Overview
  • 23.2. North America Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mammalian Cell Fermentation Technology Market

  • 24.1. USA Mammalian Cell Fermentation Technology Market Overview
  • 24.2. USA Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mammalian Cell Fermentation Technology Market

  • 25.1. Canada Mammalian Cell Fermentation Technology Market Overview
  • 25.2. Canada Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mammalian Cell Fermentation Technology Market

  • 26.1. South America Mammalian Cell Fermentation Technology Market Overview
  • 26.2. South America Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mammalian Cell Fermentation Technology Market

  • 27.1. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mammalian Cell Fermentation Technology Market

  • 28.1. Middle East Mammalian Cell Fermentation Technology Market Overview
  • 28.2. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mammalian Cell Fermentation Technology Market

  • 29.1. Africa Mammalian Cell Fermentation Technology Market Overview
  • 29.2. Africa Mammalian Cell Fermentation Technology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Mammalian Cell Fermentation Technology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Mammalian Cell Fermentation Technology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mammalian Cell Fermentation Technology Market Competitive Landscape And Company Profiles

  • 30.1. Mammalian Cell Fermentation Technology Market Competitive Landscape
  • 30.2. Mammalian Cell Fermentation Technology Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Roche Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Mammalian Cell Fermentation Technology Market Other Major And Innovative Companies

  • 31.1. AGC Group
  • 31.2. Lonza Group Ltd.
  • 31.3. Boehringer Ingelheim GmbH
  • 31.4. Catalent Inc.
  • 31.5. Sartorius AG
  • 31.6. Samsung Biologics Co. Ltd.
  • 31.7. WuXi Biologics
  • 31.8. Biocon Limited
  • 31.9. Eppendorf AG
  • 31.10. KBI Biopharma Inc.
  • 31.11. Fujifilm Diosynth Biotechnologies
  • 31.12. Avid Bioservices Inc.
  • 31.13. BiOZEEN
  • 31.14. Nordmark Pharma GmbH
  • 31.15. Scorpius BioManufacturing Inc

32. Global Mammalian Cell Fermentation Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mammalian Cell Fermentation Technology Market

34. Recent Developments In The Mammalian Cell Fermentation Technology Market

35. Mammalian Cell Fermentation Technology Market High Potential Countries, Segments and Strategies

  • 35.1 Mammalian Cell Fermentation Technology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Mammalian Cell Fermentation Technology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Mammalian Cell Fermentation Technology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer